Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gains from Sales and Divestitures (2016 - 2025)

Sonoma Pharmaceuticals has reported Gains from Sales and Divestitures over the past 10 years, most recently at $9538.0 for Q1 2025.

  • For Q1 2025, Gains from Sales and Divestitures fell 96.2% year-over-year to $9538.0; the TTM value through Mar 2025 reached $9538.0, down 96.2%, while the annual FY2025 figure was $9538.0, 96.2% down from the prior year.
  • Gains from Sales and Divestitures for Q1 2025 was $9538.0 at Sonoma Pharmaceuticals, roughly flat from $9538.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $251000.0 in Q4 2023 and troughed at $833.0 in Q3 2021.
  • A 5-year average of $92014.0 and a median of $9538.0 in 2024 define the central range for Gains from Sales and Divestitures.
  • On a YoY basis, Gains from Sales and Divestitures climbed as much as 1959.57% in 2024 and fell as far as 96.2% in 2024.
  • Year by year, Gains from Sales and Divestitures stood at $833.0 in 2021, then surged by 191.6% to $2429.0 in 2022, then soared by 10233.47% to $251000.0 in 2023, then plummeted by 96.2% to $9538.0 in 2024, then changed by 0.0% to $9538.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for SNOA at $9538.0 in Q1 2025, $9538.0 in Q4 2024, and $9538.0 in Q3 2024.